openPR Logo
Press release

Beta-Glucanase Market Value Share, Supply Demand, share and Value Chain 2016-2026

01-08-2019 02:15 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Future Market Insights

Beta-Glucanase Market Value Share, Supply Demand, share

With burgeoning advancements in science & technology, capabilities to synthesize molecules from naturally occurring sources has become increasingly popular. The advent or Amoxicillin, a semi synthetic version of Penicillin, has become one of the most widely used antibiotic in the world. Science has ventured deeper into the molecules that govern the physiology of our being and tried the same process of synthesis with other molecules and has succeeded. One of the most common semi synthetic molecules in production are enzymes. Applications of enzymes are not just limited to healthcare. Their applications also extend to the industrial and agricultural sector. Beta-glucanase is a carbohydrate enzyme that has shown to be a winner in all the aforementioned industries and more.

Beta glucans are polysaccharides occurring in the cell walls of cereals, plant fibers, fungi, yeast and bacteria. These polysaccharides are tenacious with respect to their breakdown. Beta-glucanase is a carbohydrate enzyme that breaks down the complex glycosidic bonds of beta glucans. Beta glucans being widely utilized in the food & beverages, industrial and healthcare sector call for the functionality of beta-glucanase.

Beta-glucanase Market- Market Segmentation, Market Dynamics, Regional Outlook and Major Players:

Based on the source type, the Beta-glucanasemarket is segmented into: Plant, Animal, fungi, Bacteria; Based on end use, the Beta-glucanasemarket is segmented into: Industrial, Agriculture, Healthcare, Food & beverage, Waste treatment

In today’s fast moving world, optimal percentage of macro nutrient intake is not taken seriously. This leads to effects of indigestion like gasses and bloating. Beta-glucanase positively impact the digestion process brought about by enhanced break down of carbohydrates and proteins. Beta-glucanase also breakdown the cell walls of yeasts and fungi. Beta-glucanase can be used as a substitute for anti-biotic in the treatment of candidiasis. The rising awareness vis-à-vis healthcare and nutraceuticals, we can expect to see a significant rise in the beta-glucanase market. In the beverages industry, especially during wine making, filtration is an important step in the process.

Buy This Report@ https://www.futuremarketinsights.com/checkout/2089

However, sometimes due to the high viscosity of the wine, filtration becomes a problem. In order to reduce the viscosity beta-glucanase is widely used in brewery. With the ever-growing beverages market, we can expect to see ca expect to see a significant rise in demand for beta- glucanase. Beta-glucanase is also being utilized in the process of waste treatment. The enzyme being stable at varying temperatures also makes it a perfect candidate for the industrial sector. With industrialization showing an upward curve, especially in the Asia Pacific region, we can expect a greater demand for beta-glucanase through the forecasted period of 2016-2024.

In terms of geography, the beta-glucanase market has been divided in to five key regions; North America, Latin America, Europe, Asia-Pacific and Middle East & Africa. The beta-glucanase market is expected to exhibit an above average CAGR during the forecast period. Asia Pacific and Middle East region is expected to witness a high demand for beta-glucanase over the forecasted period. Highest growth is expected to be seen specifically from India and China. Significant growth will also be witnessed in Africa and Latin America.

Some of the key players in the beta-glucanase market are Sunson Industry Group Co., Ltd., Prokazyme, Sigma-Aldrich Co. LLC, American Biosystems, Inc., SinoBios group, Noor Enzymes, Pvt. Ltd.

Request For Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2089

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +13479183531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Beta-Glucanase Market Value Share, Supply Demand, share and Value Chain 2016-2026 here

News-ID: 1479970 • Views:

More Releases from Future Market Insights

External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,

All 5 Releases


More Releases for Beta

Beta-lactam and Beta-lactamase Inhibitors Market Emerging Trends and Growth Pros …
The global beta-lactam and beta-lactamase inhibitors market is valued at approximately $60 billion in 2024, driven by the rising prevalence of bacterial infections and the increasing resistance to traditional antibiotics. The market is projected to reach around $85 billion by 2034, reflecting a robust growth trajectory. This results in a Compound Annual Growth Rate (CAGR) of approximately 6.5% during the forecast period of 2025-2034. Exactitude Consultancy., Ltd. released a research report
Beta-Lactams & Beta-Lactamase Inhibitors: A Persistent Powerhouse in the Antibio …
The antibiotics market, despite facing challenges, remains a critical sector in global healthcare. Within this landscape, the Beta-Lactam and Beta-Lactamase Inhibitor segment stands out as a high-opportunity area, driven by the continued prevalence of bacterial infections and the ongoing fight against antimicrobial resistance (AMR). Market Dynamics and Growth Drivers Beta-lactam antibiotics, including penicillins and cephalosporins, have been the cornerstone of antibacterial therapy for decades. Their broad spectrum of activity and generally favorable
apuem - beta
Today the beta phase of apuem starts. Our goal is to create the largest web app collection, and for that we need your help. So if you know a useful online tool that you like to use, suggest it to us. See more: apuem.com/suggestions We appreciate any kind of participation. Thank you very much! Apuem Finkenhofstraße 27 60322 Frankfurt am Main Germany Jacob Kearson support@apuem.com More Information: apuem.com/contact We and our community search for the best web apps
Beta-lactam and Beta-lactamase Inhibitors Market to Reach $34,170 Million by 202 …
Global beta-lactam and beta-lactamase inhibitors market size was $27,126 million in 2018, and is projected to reach $34,170 million by 2028, growing at a CAGR of 2.3% from 2019 to 2028. The cephalosporin segment accounted more than two-fifths of the total beta-lactam and beta-lactamase inhibitors market share in 2018. Download Report Sample PDF @ https://www.alliedmarketresearch.com/request-sample/5427 Beta-lactam and beta-lactamase inhibitors are chemical compounds of natural or semi-synthetic or synthetic origin. They inhibit
Beta-lactam and Beta-lactamase Inhibitors Market Outlook from 2019 to 2028
"According to a new report published titled, ""India Heat Exchangers Market by Type, Material of Construction, and End-User Industry: Opportunity Analysis and Industry Forecast, 2019-2026,"" the India heat exchangers market accounted for revenue of $454.4 million in 2018, and is anticipated to generate $890.0 million by 2026. The market is projected to grow at a CAGR of 8.6% from 2019 to 2026. Heat exchangers are devices that transfer energy between fluids
Beta-lactam and Beta-lactamase Inhibitors Market Size, Share, Development by 202 …
Global Info Research offers a latest published report on Beta-lactam and Beta-lactamase Inhibitors Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Beta-lactam and Beta-lactamase Inhibitors players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Beta-lactam and Beta-lactamase